doi: 10.3389/fimmu.2021.792711 Received 11 October 2021 Accepted 25 November 2021 Published 15 December 2021 Volume 12 - 2021 Edited by Serge Nataf, Universit Claude Bernard Lyon 1, France Reviewed by Pavan Bhargava, Johns Hopkins University, United States
The altered gastric emptying and potential changes in food intake associated with semaglutide therapy may affect the absorption and metabolism of warfarin, potentially leading to fluctuations in international normalized ratio values
Fifty-four male SpragueDawley rats weighing 225300 g (Hana Laboratories) were used in this study
Readers are directed by the company to not place undue reliance on forward-looking statements contained in the release
Ek CJ, Habgood MD, Dennis R, Dziegielewska KM, Mallard C, Wheaton B, et al